Sleep Disorders Trial, Recruiting (NCT06358495)

Sleep Disorders Trial, Recruiting NCT06358495 Sponsor: University of Calgary Condition: Sleep Disorders

Printed from Voxsanity (voxsanity.com.au) — NCT06358495 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Sleep Disorders

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

People aged between 12 and 18 years old.
People who have at least one parent with a history of depression or anxiety disorders, but who do not have a significant personal history of these types of conditions themselves.
People who score 10 out of 25 or higher on a standard sleep questionnaire called the Insomnia Severity Index, suggesting at least some level of sleep difficulty.

Who may not be able to join:

People who have symptoms of sleep disorders other than insomnia, such as restless legs syndrome or breathing problems during sleep.
People who have a history of serious, untreated mental health conditions such as bipolar disorder or schizophrenia.
People who are currently having active thoughts of suicide.
People who are currently taking prescribed medications for sleep problems.
People who have experienced a moderate to severe head injury.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 26 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Daniel Kopala-Sibley, PhD, University of Calgary

Phone: 4039510811

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT06358495

Sponsor: University of Calgary

Phase: Not Applicable

Status: Recruiting

Condition: Sleep Disorders

Trial contact: 4039510811

More information: https://clinicaltrials.gov/study/NCT06358495

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

People aged between 12 and 18 years old.
People who have at least one parent with a history of depression or anxiety disorders, but who do not have a significant personal history of these types of conditions themselves.
People who score 10 out of 25 or higher on a standard sleep questionnaire called the Insomnia Severity Index, suggesting at least some level of sleep difficulty.

Who may not be able to join:

People who have symptoms of sleep disorders other than insomnia, such as restless legs syndrome or breathing problems during sleep.
People who have a history of serious, untreated mental health conditions such as bipolar disorder or schizophrenia.
People who are currently having active thoughts of suicide.
People who are currently taking prescribed medications for sleep problems.
People who have experienced a moderate to severe head injury.

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 26 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

University of Calgary

Registry

ClinicalTrials.gov

Start date

1 November 2024

Est. completion

30 June 2025

Where this trial is recruiting

🇨🇦 Canada

Primary endpoints

Insomnia Severity Index; Pittsburgh Sleep Quality Index; Internalizing Symptoms Subscale of the Youth Self-Report

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov